Vaccines that generate high levels of antibodies do not necessarily generate high levels of T cells. Development of vaccines must incorporate the viral components that T cells recognise and react ...

Findings challenge the longstanding reliance on neutralising antibodies for assessing viral immunity, and suggest that development of future vaccines must consider both antibody and T-cell ...